Fundz

Erasca Extends Series B Financing to $236 Million

PUBLIC · ERASAug 31, 2020

Amount Raised

$236 Million

Round Type

Series B

San DiegoBiotechnology

Description

Erasca, a company whose mission is to erase cancer, today announced the completion of a $36 million extension of its Series B financing round, which brings the total round to $236 million. New investors include Partner Fund Management and OrbiMed.

Quick answer

Erasca, Inc. raised $236 Million in a Series B round, dated August 31, 2020. Erasca, Inc. is based in San Diego, California, United States.

How much did Erasca, Inc. raise?
Erasca, Inc. raised $236 Million in a Series B round on August 31, 2020.
What does Erasca, Inc. do?
Erasca creating a new generation of oncology drugs intended to not just treat, but actually cure Cancer.
Where is Erasca, Inc. based and how big is it?
Erasca, Inc. is based in San Diego, California, United States. Fundz records about 120 employees.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Erasca, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Alucent Biomedical, Inc. raised $35M on October 15, 2020.
  • ORTHO REGENERATIVE TECHNOLOGIES INC. raised $73K (Pre-Seed) on October 15, 2020.
  • Azitra raised an undisclosed amount (Series B) on October 15, 2020.
  • SRX Global Inc. raised $19M on October 15, 2020.
  • Evofem Biosciences raised $25M (Corporate Round) on October 15, 2020.
  • Counterpoint Health Solutions, Inc. raised $3.8M (Seed) on October 15, 2020.

Who to call at Erasca, Inc., and when

A new round usually means Erasca, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Erasca, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Erasca, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Erasca, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Erasca, Inc.

Location

10835 Road to The Cure, Ste. 140

San Diego, California, United States

About

Erasca creating a new generation of oncology drugs intended to not just treat, but actually cure Cancer.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Erasca, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Erasca, Inc.'s next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

Erasca, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.